These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 33880614)

  • 1. Validation of the atherothrombotic risk score for secondary prevention in patients with acute myocardial infarction: the J-MINUET study.
    Hashimoto T; Minami Y; Ako J; Nakao K; Ozaki Y; Kimura K; Noguchi T; Suwa S; Fujimoto K; Nakama Y; Morita T; Shimizu W; Saito Y; Hirohata A; Morita Y; Inoue T; Okamura A; Mano T; Hirata K; Tanabe K; Shibata Y; Owa M; Tsujita K; Funayama H; Kokubu N; Kozuma K; Uemura S; Tobaru T; Saku K; Oshima S; Nishimura K; Miyamoto Y; Ogawa H; Ishihara M;
    Heart Vessels; 2021 Oct; 36(10):1506-1513. PubMed ID: 33880614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Committee.
    Mok Y; Ballew SH; Bash LD; Bhatt DL; Boden WE; Bonaca MP; Carrero JJ; Coresh J; D'Agostino RB; Elley CR; Fowkes FGR; Jee SH; Kovesdy CP; Mahaffey KW; Nadkarni G; Peterson ED; Sang Y; Matsushita K
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 29982232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and outcome across the spectrum of high-risk patients with myocardial infarction according to the thrmobolysis in myocardial infarction (TIMI) risk-score for secondary prevention.
    Grinberg T; Bental T; Hammer Y; Assali A; Vaknin-Assa H; Wiessman M; Perl L; Kornowski R; Eisen A
    Clin Cardiol; 2021 Nov; 44(11):1535-1542. PubMed ID: 34469003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarction.
    Williams BA; Chagin KM; Bash LD; Boden WE; Duval S; Fowkes FGR; Mahaffey KW; Patel MD; D'Agostino RB; Peterson ED; Kattan MW; Bhatt DL; Bonaca MP
    Atherosclerosis; 2018 May; 272():80-86. PubMed ID: 29579671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Risk Stratification of Patients Undergoing Coronary Angiography According to the Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention.
    Zafrir B; Adawi S; Khalaily M; Jaffe R; Eitan A; Barnett-Griness O; Saliba W
    J Am Heart Assoc; 2019 Jul; 8(14):e012433. PubMed ID: 31271083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Impact of Polyvascular Disease in Patients With Acute Myocardial Infarction in the Contemporary Era of Percutaneous Coronary Intervention　- Insights From the Japan Acute Myocardial Infarction Registry (JAMIR).
    Arai R; Okumura Y; Murata N; Fukamachi D; Honda S; Nishihira K; Kojima S; Takegami M; Asaumi Y; Yamashita J; Saji M; Hibi K; Takahashi J; Sakata Y; Takayama M; Sumiyoshi T; Ogawa H; Kimura K; Yasuda S;
    Circ J; 2024 May; 88(6):911-920. PubMed ID: 38008436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIMI risk score for secondary prevention of recurrent cardiovascular events in a real-world cohort of post-non-ST-elevation myocardial infarction patients.
    Huang D; Cheng YY; Wong YT; Yung SY; Chan KW; Lam CC; Hai J; Lau CP; Wong KL; Feng YQ; Tan N; Chen JY; Wu MX; Su X; Yan H; Song D; Tse HF; Chan PH; Siu CW; Tam CC
    Postgrad Med J; 2019 Jul; 95(1125):372-377. PubMed ID: 31123174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Chronic Kidney Disease on In-Hospital and 3-Year Clinical Outcomes in Patients With Acute Myocardial Infarction Treated by Contemporary Percutaneous Coronary Intervention and Optimal Medical Therapy　- Insights From the J-MINUET Study.
    Hashimoto Y; Ozaki Y; Kan S; Nakao K; Kimura K; Ako J; Noguchi T; Suwa S; Fujimoto K; Dai K; Morita T; Shimizu W; Saito Y; Hirohata A; Morita Y; Inoue T; Okamura A; Mano T; Wake M; Tanabe K; Shibata Y; Owa M; Tsujita K; Funayama H; Kokubu N; Kozuma K; Uemura S; Tobaru T; Saku K; Oshima S; Yasuda S; Ismail TF; Muramatsu T; Izawa H; Takahashi H; Nishimura K; Miyamoto Y; Ogawa H; Ishihara M;
    Circ J; 2021 Sep; 85(10):1710-1718. PubMed ID: 34078824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Presentation, Management and Outcome of Japanese Patients With Acute Myocardial Infarction in the Troponin Era - Japanese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition (J-MINUET) - .
    Ishihara M; Fujino M; Ogawa H; Yasuda S; Noguchi T; Nakao K; Ozaki Y; Kimura K; Suwa S; Fujimoto K; Nakama Y; Morita T; Shimizu W; Saito Y; Tsujita K; Nishimura K; Miyamoto Y;
    Circ J; 2015; 79(6):1255-62. PubMed ID: 25912696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
    Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical impact of Academic Research Consortium for High Bleeding-Risk scores on clinical outcomes in patients with stable coronary artery disease undergoing percutaneous coronary intervention.
    Shimono H; Tokushige A; Kanda D; Ohno A; Arikawa R; Chaen H; Okui H; Oketani N; Ohishi M
    Heart Vessels; 2024 Dec; 39(12):995-1008. PubMed ID: 38842586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and outcomes over time of acute coronary syndrome patients at particularly high cardiovascular risk : the ACSIS registry-based retrospective study.
    Grinberg T; Hammer Y; Wiessman M; Perl L; Ovdat T; Tsafrir O; Kogan Y; Beigel R; Orvin K; Kornowski R; Eisen A
    BMJ Open; 2022 Apr; 12(4):e060953. PubMed ID: 35410940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherothrombotic risk stratification after acute myocardial infarction: The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention in the light of the French Registry of Acute ST Elevation or non-ST Elevation Myocardial Infarction registries.
    Puymirat E; Bonaca M; Fumery M; Tea V; Aissaoui N; Lemesles G; Bonello L; Ducrocq G; Cayla G; Ferrières J; Schiele F; Simon T; Danchin N;
    Clin Cardiol; 2019 Feb; 42(2):227-234. PubMed ID: 30536449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between thrombolysis in myocardial infarction risk index and the severity of coronary artery lesions and long-term outcome in acute myocardial infarction patients undergoing percutaneous coronary intervention].
    Chen Y; Song Y; Xu JJ; Tang XF; Wang HH; Jiang P; Jiang L; Liu R; Zhao XY; Gao LJ; Song L; Zhang Y; Chen J; Gao Z; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Nov; 46(11):874-881. PubMed ID: 30462976
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictive value of the Canada Acute Coronary Syndrome risk score for post-acute myocardial infarction infection.
    Liu Y; Dai Y; Chen J; Huang C; Duan C; Shao S; Chen H; Xue L; Yu D; Chen J; Tan N; He P
    Eur J Intern Med; 2020 Jan; 71():57-61. PubMed ID: 31732453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of a Risk Score for Predicting Post-acute Myocardial Infarction Infection in Patients Undergoing Percutaneous Coronary Intervention: Study Protocol for an Observational Study.
    Liu Y; Wang L; Lin Y; Chen W; Xu Z; Chen P; Dai Y; Zeng L; Fan H; Xue L; Chen J; Tan N; Duan C; He P
    Front Cardiovasc Med; 2021; 8():675142. PubMed ID: 34124203
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk Estimation for Infection in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Development and Validation of a Predictive Score.
    Liu Y; Wang L; Chen P; Dai Y; Lin Y; Chen W; Xu Z; Zeng L; Fan H; Xue L; Liu S; Chen J; Tan N; He P; Duan C
    Front Cardiovasc Med; 2022; 9():845307. PubMed ID: 35497986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
    Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lower eicosapentaenoic acid/arachidonic acid ratio is associated with in-hospital fatal arrhythmic events in patients with acute myocardial infarction: a J-MINUET substudy.
    Hashimoto T; Ako J; Nakao K; Ozaki Y; Kimura K; Noguchi T; Yasuda S; Suwa S; Fujimoto K; Nakama Y; Morita T; Shimizu W; Saito Y; Hirohata A; Morita Y; Inoue T; Okamura A; Uematsu M; Hirata K; Tanabe K; Shibata Y; Owa M; Tsujita K; Funayama H; Kokubu N; Kozuma K; Uemura S; Toubaru T; Saku K; Ohshima S; Nakai M; Nishimura K; Miyamoto Y; Ogawa H; Ishihara M;
    Heart Vessels; 2018 May; 33(5):481-488. PubMed ID: 29147787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention of Recurrent Cardiovascular Events in a Real-World Cohort of Post-Acute Myocardial Infarction Patients.
    Huang D; Cheng YY; Wong YA; Yung SA; Tam CF; Chan KK; Lam CS; Yiu KH; Hai JJ; Lau CP; Chan EW; Chiang CE; Wong KL; Cheung T; Cheung BM; Feng YQ; Tan N; Chen JY; Yue WS; Hu HX; Chen L; Tse HF; Chan PH; Siu CW
    Circ J; 2019 Mar; 83(4):809-817. PubMed ID: 30799311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.